THANK YOU FOR SUBSCRIBING
Halo Labs leverages AI and machine learning to power the image analysis algorithms that are tuned for the context in which they are executed. According to Wicke, these algorithms “understand” the membrane and identify particles and proteins based on HORIZON’s BMI technology. Further, as more customers start using Halo’s system, the algorithms intuitively learn how different types of particles behave on the membrane. This information on particulates and proteins is helping Halo Labs develop future products that can better identify particles by leveraging software, AI, and hardware techniques.![]()
Unlike other particle analysis systems that require milliliters of a sample to produce effective results, HORIZON delivers the same outcome with 25-50 microliters
Share this Article:
Tweet
|
Company
Halo Labs
Headquarters
Burlingame, CA
Management
Robert Wicke, CEO & Dr. John Proctor, VP of marketing
Description
Halo Labs (formerly Optofluidics) is a venture-backed scientific instrumentation and consumable company that commercializes high-throughput biopharmaceutical formulation and quality control tools for particle analysis using state-of-the-art custom optics and image processing techniques. Halo Labs’ core mission has been to provide researchers with unprecedented insights into the particles present in their processes by leveraging our core scientific competency: optical imaging on membranes. Over the years, Halo Labs has been the recipient of many prestigious awards, and has received over $6M in research grants from agencies including DARPA, FDA, NSF, NIST and NIH. Today, we dedicate our collective experience and novel technology to empower formulation researchers to learn more about the stability and quality of their biological drugs faster and with more accuracy than ever before